The present study will evaluate the safety and efficacy of the Chinese herb huperzine A in
the treatment of Alzheimer's disease (AD) in a randomized controlled trial of its effect on
cognitive function.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Aging (NIA)
Collaborators:
Alzheimer's Disease Cooperative Study (ADCS) Neuro-Hitech